SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 194 filers reported holding SAGE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $6,465,000 | -22.9% | 105,771 | +77.0% | 0.70% | -0.9% |
| Q3 2019 | $8,384,000 | -41.0% | 59,761 | -23.0% | 0.70% | -45.9% |
| Q2 2019 | $14,211,000 | +11.4% | 77,616 | -3.2% | 1.30% | +14.7% |
| Q1 2019 | $12,752,000 | +149.5% | 80,178 | +50.3% | 1.14% | +106.7% |
| Q4 2018 | $5,112,000 | -54.3% | 53,363 | -32.6% | 0.55% | -38.7% |
| Q3 2018 | $11,184,000 | -11.8% | 79,176 | -2.2% | 0.90% | +0.7% |
| Q2 2018 | $12,678,000 | +27.1% | 80,994 | +30.7% | 0.89% | +24.8% |
| Q1 2018 | $9,978,000 | -22.4% | 61,946 | -20.7% | 0.71% | +68.0% |
| Q4 2017 | $12,864,000 | +389.7% | 78,104 | +85.2% | 0.42% | +133.5% |
| Q3 2017 | $2,627,000 | -56.5% | 42,173 | -44.4% | 0.18% | -57.3% |
| Q2 2017 | $6,036,000 | +11.6% | 75,805 | -0.3% | 0.43% | +11.8% |
| Q1 2017 | $5,408,000 | +21.6% | 76,059 | -12.7% | 0.38% | +13.1% |
| Q4 2016 | $4,448,000 | +35.1% | 87,159 | +21.9% | 0.34% | +53.9% |
| Q3 2016 | $3,292,000 | +75.3% | 71,483 | +22.0% | 0.22% | +59.9% |
| Q1 2016 | $1,878,000 | -47.9% | 58,580 | -5.2% | 0.14% | -45.0% |
| Q4 2015 | $3,602,000 | +23.1% | 61,789 | -10.6% | 0.25% | +18.6% |
| Q3 2015 | $2,925,000 | -29.4% | 69,127 | +21.8% | 0.21% | -20.8% |
| Q2 2015 | $4,143,000 | +46.7% | 56,752 | +0.9% | 0.26% | +49.7% |
| Q1 2015 | $2,825,000 | +18.4% | 56,246 | -13.7% | 0.18% | +18.8% |
| Q4 2014 | $2,386,000 | +18.0% | 65,186 | +1.6% | 0.15% | +18.3% |
| Q3 2014 | $2,022,000 | – | 64,185 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 179,200 | $29,516,000 | 16.65% |
| TRV GP II, LLC | 547,916 | $90,247,000 | 16.25% |
| Opus Point Partners Management, LLC | 71,000 | $11,694,000 | 10.12% |
| Casdin Capital, LLC | 250,000 | $41,178,000 | 10.03% |
| RA Capital Management | 455,173 | $74,972,000 | 6.27% |
| Crawford Lake Capital Management, LLC | 154,278 | $25,411,000 | 6.00% |
| Palo Alto Investors LP | 810,806 | $133,548,000 | 5.75% |
| GREAT POINT PARTNERS LLC | 200,000 | $32,942,000 | 5.62% |
| BB BIOTECH AG | 1,042,439 | $171,700,000 | 4.84% |
| Crawford Lake Capital Management, LLC | 92,300 | $15,203,000 | 3.59% |